Abstract:Ghrelin is the only known orexigenic gut hormone, and its synthesis, secretion and degradation are affected by different metabolic statuses. This meta-analysis aimed to investigate the potential differences in plasma acyl ghrelin (AG) and des-acyl ghrelin (DAG) concentrations between normal weight and obese adults. Systematic literature searches of PubMed, Embase and Web of Science through October 2021 were conducted for articles reporting AG or DAG levels in obesity and normal weight, and 34 studies with 1863 participants who met the eligibility criteria were identified. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated to evaluate group differences in circulating AG and DAG levels. Pooled effect size showed significantly lower levels of baseline AG (SMD: − 0.85; 95% CI: − 1.13 to − 0.57; P SMD < 0.001) and DAG (SMD: − 1.06; 95% CI: − 1.43 to − 0.69; P SMD < 0.001) in obese groups compared with healthy controls, and similar results were observed when subgroup analyses were stratified by the assay technique or storage procedure. Postprandial AG levels in obese subjects were significantly lower than those in controls when stratified by different time points (SMD 30 min : − 0.85, 95% CI: − 1.18 to − 0.53, P SMD < 0.001; SMD 60 min : − 1.00, 95% CI: − 1.37 to − 0.63, P SMD < 0.001; SMD 120 min : − 1.21, 95% CI: − 1.59 to − 0.83, P SMD < 0.001). In healthy subjects, a postprandial decline in AG was observed at 120 min (SMD: − 0.42; 95% CI: − 0.77 to − 0.06; P SMD = 0.021) but not in obese subjects (SMD: − 0.28; 95% CI: − 0.60 to 0.03; P SMD = 0.074). The mean change in AG concentration was similar in both the obese and lean health groups at each time point (ΔSMD 30min : 0.31, 95% CI: − 0.35 to 0.97, P SMD = 0.359; ΔSMD 60min : 0.17, 95% CI: − 0.12 to 0.46, P SMD = 0.246; ΔSMD 120min : 0.21, 95% CI: − 0.13 to 0.54, P SMD = 0.224). This meta-analysis strengthens the clinical evidence supporting the following: lower baseline levels of circulating AG and DAG in obese individuals; declines in postprandial circulating AG levels, both for the healthy and obese individuals; a shorter duration of AG suppression in obese subjects after meal intake. These conclusions have significance for follow-up studies to elucidate the role of various ghrelin forms in energy homeostasis.

Plasma Ghrelin Levels and Weight Loss in Chinese Uygur Patients with Chronic Obstructive Pulmonary Disease.

Circulating Ghrelin in Patients with Chronic Obstructive Pulmonary Disease

Elevated circulating ghrelin in patients with COPD: A meta-analysis.

Factors Associated with Fasting Plasma Ghrelin Levels in Children and Adolescents

Circulating Acyl and Des-Acyl Ghrelin Levels in Obese Adults: a Systematic Review and Meta-Analysis

Relation of Nutritional Status and Plasma Ghrelin Level of Patients in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Serum Levels of IGFBP7 Are Elevated During Acute Exacerbation in COPD Patients.

Evaluation of Ghrelin Level and Appetite Regulation in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Increased Circulating Obestatin in Patients with Chronic Obstructive Pulmonary Disease

Regulation of Ghrelin on Appetite in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Changes of plasma inflammatory factors and ghrelin in patients with acute exacerbation of chronic obstructive pulmonary disease

Plasma Ghrelin Levels Are Closely Associated with Severity and Morphology of Angiographically-Detected Coronary Atherosclerosis in Chineses Patients with Diabetes Mellitus

Circulating Ghrelin in Patients with Gastric or Colorectal Cancer

Serum Ghrelin And Esophageal And Gastric Cancer In Two Cohorts In China

Disturbance of Circulating Ghrelin and Obestatin in Chronic Heart Failure Patients Especially in Those with Cachexia

Circulating ghrelin levels in patients with gastric cancer: a systematic review and meta-analysis

Plasma Orexin-A Levels in COPD Patients with Hypercapnic Respiratory Failure

Plasma ghrelin levels and polymorphisms of ghrelin gene in Chinese obese children and adolescents

Plasma Gherlin Levels in Patients Undergoing Hemodialysis and Peritoneal Dialysis

The Correlation Between Circulating Ghrelin and Insulin Resistance in Obesity: A Meta-Analysis

Ghrelin and Obestatin Levels in Hypertensive Obese Patients